Amgen Wins Patent Case On Enbrel® (etanercept)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. MDT
2. ENOV
3. BLSM
4. AON
5. AZN
6. GRMN
7. PTGX
8. AAPL
9. LTGO
10. KRMN

Go back to Amgen Wins Patent Case On Enbrel® (etanercept)
Amgen Inc (NASDAQ: AMGN) Delayed: 429.88 --0 (-0%)
Previous Close $429.88    52 Week High $176.85 
Open $429.88    52 Week Low $133.64 
Day High $429.88    P/E 64.74 
Day Low $429.88    EPS $6.64 
Volume 2,146